CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.

Altre lingue China Resources Double-Crane Pharmaceutical Co.,Ltd.

Azioni

600062

CNE000000Q94

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
21,77 ^CNY	+2,01%		+1,82%	+17,04%

26/04	L'utile di CR Double-Crane Pharmaceutical aumenta dell'11% nel primo trimestre, mentre le entrate crescono del 2%.	MT
26/04	L'unità di CR Double-Crane Pharmaceutical ottiene l'autorizzazione a sperimentare un nuovo farmaco per il dolore	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2%	26/04
CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication	26/04
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
CR Double-Crane Pharmaceutical Gets Nod to Trial Semaglutide Injection	16/04
CR Double-Crane Pharma Unit Receives Approval for Epilepsy Drug	26/03
CR Double-Crane Pharma's 2023 Profit Jumps 13%, Operating Income Climbs 6%	22/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. Proposes Cash Dividend	21/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
CR Double-crane Pharmaceutical Gets Nod to Market Doxazosin Mesylate Tablets	12/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire China Resources Zizhu Pharmaceutical Co., Ltd. from Beijing Pharmaceutical Group Co., Ltd. for CNY3.1 billion.	26/02
CR Double-Crane Pharma Gets Nod for Apixaban Tablets; Unit's Clozapine Orally Disintegrating Tablets Gets Greenlight for Proposed Amendments	21/02
CR Double-Crane Pharma's Unit Gets Nod to Market Lithium Carbonate Drug Ingredient	08/02
CR Double-Crane Pharmaceutical's Unit Gets Nod to Raise Strength of Viagra Drug	31/01
China Includes CR Double-Crane Pharmaceutical's Two Drugs in List of Insurance-Backed Drugs	14/12
CR Double-Crane Pharma Unit Gets Nod to Amend Sodium Lactate Ringer Injection's Details	12/12
China Resources Double-Crane Pharmaceutical Co.,Ltd.(SHSE:600062) dropped from Shanghai Stock Exchange 180 Value Index	08/12
China Resources Double-Crane Pharmaceutical Co.,Ltd.(SHSE:600062) dropped from SSE 180 Index	08/12
China Resources Double-Crane Pharmaceutical Co.,Ltd. completed the acqyusution 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd.	03/11
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
CR Double-Crane Pharma to Buy 90% Stake in Local Peer For 260 Million Yuan	28/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue China Resources Double-Crane Pharmaceutical Co.,Ltd.

Azioni

600062

CNE000000Q94

Altre lingue

Filtri